Journey Medical Corporation Annual report [Section 13 and 15(d), not S-K Item 405]

Annual report [Section 13 and 15(d), not S-K Item 405]

SEGMENT INFORMATION (Tables)

SEGMENT INFORMATION (Tables)

12 Months Ended

Dec. 31, 2024


	Year Ended December 31,
($in thousands)	2024		2023
Revenue	$	56,134	$	79,181
Less: Segment Expenses⁽¹⁾
Cost of goods sold – (excluding amortization of acquired intangible assets)		20,879		22,893
Research and development		9,857		7,541
Selling, general and administrative
Employee related		14,765		19,190
Sales, operations, outside services and consulting		9,417		11,184
Marketing related		5,258		5,099
Stock compensation		5,590		2,498
Legal and administrative		2,230		2,066
Product compliance expense		1,632		1,803
Office and administrative		739		855
Other		573		1,215
Other segment items⁽²⁾		(134)		8,690
Segment expenses		70,806		83,034
Net loss	$	(14,672)	$	(3,853)

Reconciliation of net loss:
Adjustments and reconciling items		—		—
Net loss	$	(14,672)	$	(3,853)

(1)The significant expense amounts align with the expenses that the CODM is regularly provided with to assess performance and allocate resources.

(2)Other segment items for the reportable segment include amortization of intangible assets, loss on impairment of intangible assets, loss recovery, interest income (expense), gain on extinguishment of debt, foreign exchange transaction losses and income tax expense.